Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Nat Protoc. 2019 Feb;14(2):441-460. doi: 10.1038/s41596-018-0100-z.
Although protein synthesis is a conserved and essential cellular function, it is often regulated in a cell-type-specific manner to influence cell fate, growth and homeostasis. Most methods used to measure protein synthesis depend on metabolically labeling large numbers of cells with radiolabeled amino acids or amino acid analogs. Because these methods typically depend on specialized growth conditions, they have been largely restricted to yeast, bacteria and cell lines. Application of these techniques to investigating protein synthesis within mammalian systems in vivo has been challenging. The synthesis of O-propargyl-puromycin (OP-Puro), an analog of puromycin that contains a terminal alkyne group, has facilitated the quantification of protein synthesis within individual cells in vivo. OP-Puro enters the acceptor site of ribosomes and incorporates into nascent polypeptide chains. Incorporated OP-Puro can be detected through a click-chemistry reaction that links it to a fluorescently tagged azide molecule. In this protocol, we describe how to administer OP-Puro to mice, obtain cells of interest (here, we use bone marrow cells) just 1 h later, and quantify the amount of protein synthesized per hour by flow cytometry on the basis of OP-Puro incorporation. We have used this approach to show that hematopoietic stem cells (HSCs) exhibit an unusually low rate of protein synthesis relative to other hematopoietic cells, and it can be easily adapted to quantify cell-type-specific rates of protein synthesis across diverse mammalian tissues in vivo. Measurement of protein synthesis within bone marrow cells in a cohort of six mice can be achieved in 8-10 h.
尽管蛋白质合成是一种保守且必需的细胞功能,但它通常以细胞类型特异性的方式进行调节,以影响细胞命运、生长和内稳态。大多数用于测量蛋白质合成的方法都依赖于用放射性标记的氨基酸或氨基酸类似物代谢标记大量细胞。由于这些方法通常依赖于专门的生长条件,因此它们主要限于酵母、细菌和细胞系。将这些技术应用于研究体内哺乳动物系统中的蛋白质合成具有挑战性。O-炔丙基-嘌呤霉素(OP-Puro)的合成,一种含有末端炔基的嘌呤霉素类似物,促进了体内单个细胞中蛋白质合成的定量。OP-Puro 进入核糖体的接受位点并掺入新生多肽链中。掺入的 OP-Puro 可以通过点击化学反应来检测,该反应将其与荧光标记的叠氮化物分子连接。在本协议中,我们描述了如何向小鼠给药 OP-Puro,然后在 1 小时后获得感兴趣的细胞(在这里,我们使用骨髓细胞),并根据 OP-Puro 的掺入通过流式细胞术来量化每小时合成的蛋白质量。我们已经使用这种方法表明造血干细胞 (HSCs) 相对于其他造血细胞表现出异常低的蛋白质合成率,并且可以轻松适应在体内定量不同哺乳动物组织中的细胞类型特异性蛋白质合成率。对六只小鼠的骨髓细胞中的蛋白质合成进行测量可以在 8-10 小时内完成。